Hospital Universitario son Espases

Palma de Mallorca 07210

4 studies enrolling now · 16 studies all time

What they study most

Acute Coronary Syndrome, Advanced Breast Cancer, Aortic Dissection, Aortic Valve Disease, Ascending Aorta Abnormality, Atrial Fibrillation, Breast Cancer, Chronic Myelomonocytic Leukemia, Community-acquired Pneumonia, Coronary Artery Disease, HER2+ Metastatic Breast Cancer (MBC), HER2- Negative Breast Cancer

Studies at this site

• Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer — Recruiting now
• Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) — Recruiting now
• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• Valved Graft PMCF Study — Recruiting now
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
• EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease — Stopped early
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices — Running, not enrolling
• Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma — Completed
• KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment — Status unconfirmed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• Personalized CRT - MPP Post Approval Study — Completed
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed
• PRESSUREwire Study — Completed